Doç. Dr. Pınar Tığlıoğlu

Real-world effectiveness and safety of fixed-duration frontline venetoclax–obinutuzumab for chronic lymphocytic leukemia: A nationwide multicenter retrospective cohort study

Leukemia Research, 2026

DOI 10.1016/j.leukres.2026.108342 PMID 42933070 Quelle: OpenAlex

Ferritin and LDH predict thrombotic risk beyond conventional scoring systems in DLBCL

Annals of Hematology, 2026

DOI 10.1007/s00277-026-07201-y PMID 42897372 Frei zugänglicher VolltextQuelle: ORCID

Publication Only

HemaSphere, 2026

DOI 10.1002/hem3.70421 Frei zugänglicher VolltextQuelle: OpenAlex

Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin

Journal of Clinical Medicine, 2025

DOI 10.3390/jcm14207294 PMID 41156164 Frei zugänglicher VolltextQuelle: OpenAlex

Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group

Journal of Clinical Medicine, 2025

DOI 10.3390/jcm14196813 PMID 41095893 Frei zugänglicher VolltextQuelle: OpenAlex

Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients

Annals of Hematology, 2025

DOI 10.1007/s00277-025-06644-z PMID 41074982 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Immunological biomarkers and TARC/CCL17 in myelodysplastic syndrome: Insights into immune microenvironment regulation

Blood, 2025

DOI 10.1182/blood-2025-7359 Frei zugänglicher VolltextQuelle: OpenAlex

CURRENT TREATMENT METHODS FOR EARLY RELAPSED MULTIPLE MYELOMA

Turkiye Klinikleri eBooks, 2025

DOI 10.5336/978-625-395-694-3_p55 Quelle: OpenAlex

A challenging issue in COVID-19 infection: The relationship between PA1-1 and TAFI levels in patients with coagulation disorder: A retrospective and observational study

Medicine, 2024

DOI 10.1097/md.0000000000037802 PMID 38608056 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Change in Hepatitis B Surface Antibody Titers After Chemotherapy in Patients With Hematological Malignancies

Cureus, 2024

DOI 10.7759/cureus.51572 PMID 38314000 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

The Prognostic Impact of Comorbidity, Nutritional and Performance Status on Patients with Diffuse Large B Cell Lymphoma

Nigerian Journal of Clinical Practice, 2023

DOI 10.4103/njcp.njcp_175_23 PMID 37929528 6 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Analysis of factors associated with the development of myelofibrosis in polycythemia vera and essential thrombocythemia patients: a single-center experience

Journal of Hematopathology, 2022

DOI 10.1007/s12308-022-00488-6 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Marjinal Zon Lenfoma Tanılı Hastalarda Klinik Özellikler ve Olası Prognostik Faktörler: İki Merkezden Retrospektif Analiz

LLM Dergi, 2022

DOI 10.5578/llm.20229903 Frei zugänglicher VolltextQuelle: OpenAlex

Analysis of Demographic and Disease Characteristics of Patients with Chronic Myeloid Leukemia: A Single Centre Retrospective Analysis

Acta Oncologica Turcica, 2022

DOI 10.5505/aot.2022.08831 Frei zugänglicher VolltextQuelle: OpenAlex

Single Centre Experience: Bening and Malign Hematological Patients with COVID-19

Sağlık Akademisi Kastamonu, 2022

DOI 10.25279/sak.1061701 Frei zugänglicher VolltextQuelle: OpenAlex

Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect

Journal of Clinical Pharmacy and Therapeutics, 2022

DOI 10.1111/jcpt.13512 PMID 34423448 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Analysis of factors predicting the efficacy of Imatinib in patients with Chronic Myeloid Leukemia: A retrospective analysis

Medical Science and Discovery, 2022

DOI 10.36472/msd.v9i9.802 Frei zugänglicher VolltextQuelle: OpenAlex

RELAPSED MANTLE CELL LYMPHOMA WITH ISOLATED CENTRAL NERVOUS SYSTEM INVOLVEMENT THAT TREATED WITH IBRUTINIB; A CASE REPORT AND LITERATURE REVIEW

Hematology Transfusion and Cell Therapy, 2022

DOI 10.1016/j.htct.2022.09.1247 Frei zugänglicher VolltextQuelle: OpenAlex

Bir Pandeminin Anatomisi COVID-19

Akademisyen Kitabevi eBooks, 2022

DOI 10.37609/akya.1788 Frei zugänglicher VolltextQuelle: OpenAlex

The outcome of COVID-19 in patients with hematological malignancy

memo - Magazine of European Medical Oncology, 2021

DOI 10.1007/s12254-021-00775-5 PMID 34904019 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment

Journal of Oncology Pharmacy Practice, 2021

DOI 10.1177/10781552211060730 PMID 34775854 3 Zitationen (Europe PMC) Quelle: OpenAlex

RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)

Hematology Transfusion and Cell Therapy, 2021

DOI 10.1016/j.htct.2021.10.1057 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

A RARE CASE: POSTTRANSPLANT NK/T CELL LYMPHOMA

Hematology Transfusion and Cell Therapy, 2021

DOI 10.1016/j.htct.2021.10.1033 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

CASE REPORT: FOLLICULAR LYMPHOMA PRESENTED WITH CHYLOTHORAX

Hematology Transfusion and Cell Therapy, 2021

DOI 10.1016/j.htct.2021.10.1039 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

A VERY RARE CAUSE OF DIARRHEA IN A CHEMOTHERAPY-INDUCED NEUTROPENIC PATIENT: PELLAGRA

Hematology Transfusion and Cell Therapy, 2021

DOI 10.1016/j.htct.2021.10.1034 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

A RARE AND COMPLEX CAUSE OF IMPOTENCE POEMS SYNDROME

Hematology Transfusion and Cell Therapy, 2021

DOI 10.1016/j.htct.2021.10.1045 Frei zugänglicher VolltextQuelle: OpenAlex

CASE REPORT OF MARGINAL ZONE LYMPHOMA DETECTED WHILE INVESTIGATING ETIOLOGY FOR HEMOSTASIS DISORDER

Hematology Transfusion and Cell Therapy, 2021

DOI 10.1016/j.htct.2021.10.1030 Frei zugänglicher VolltextQuelle: OpenAlex

A RARE CAUSE OF ANEMIA IN ADULTHOOD CONGENITAL DYSERYTHROPETIC ANEMIA

Hematology Transfusion and Cell Therapy, 2021

DOI 10.1016/j.htct.2021.10.1064 Frei zugänglicher VolltextQuelle: OpenAlex

T-ACUTE MYELOID LEUKEMIA CASE THOUGHT TO BE ASSOCIATED WITH RADIOIODINE (I¹³¹) TREATMENT

Hematology Transfusion and Cell Therapy, 2021

DOI 10.1016/j.htct.2021.10.1019 Frei zugänglicher VolltextQuelle: OpenAlex

A RARE ASSOCIATION IN A CASE WITH HEREDITARY SPHEROCYTOSIS: SPECTRIN BETA (SPTB) AND JAK-2 MUTATION

Hematology Transfusion and Cell Therapy, 2021

DOI 10.1016/j.htct.2021.10.1060 Frei zugänglicher VolltextQuelle: OpenAlex

ANTI-CD52 TREATMENT EXPERIENCE IN A T-CELL PROLYMPHOCYTIC LEUKEMIA PATIENT:CASE REPORT

Hematology Transfusion and Cell Therapy, 2021

DOI 10.1016/j.htct.2021.10.1014 Frei zugänglicher VolltextQuelle: OpenAlex

INAPPROPRIATE ADH SYNDROME OCCURING DURING B-ALL TREATMENT

Hematology Transfusion and Cell Therapy, 2021

DOI 10.1016/j.htct.2021.10.1018 Frei zugänglicher VolltextQuelle: OpenAlex

A CASE OF STAGE 1E DIFFUSE LARGE B-CELL LYMPHOMA PRESENTED WITH KNEE INVOLVEMENT

Hematology Transfusion and Cell Therapy, 2021

DOI 10.1016/j.htct.2021.10.1037 Frei zugänglicher VolltextQuelle: OpenAlex

COVID-19 ve Kanser

Akademisyen Kitabevi eBooks, 2021

DOI 10.37609/akya.668 Quelle: ORCID